2030 Packaging Vaccines 
Express Pharma
JUNE 4, 2024
The premier expo opened its door to over 200 exhibitors showcasing more than 1000 brands offering insights into Machinery & Packaging, Lab Analytical & Cleanroom, and Pharma Ingredients segments The 10th edition of PharmaLytica, organised by Informa Markets in India, commenced at HITEX, Hyderabad.
Express Pharma
FEBRUARY 26, 2024
The partnership will build upon existing manufacturing capacity for the vaccine at Takeda’s facility in Singen, Germany and Takeda’s long-term partnership with IDT Biologika GmbH Takeda and Biological E. Limited, which has deep expertise in vaccine manufacturing and longstanding support of public health programs around the world.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JANUARY 4, 2024
The Indian pharma industry is on a solid growth trajectory, surging from $40 billion in 2021 to an estimated $130 billion in 2030, with a steady double-digit CAGR for the next 10 years. It meets 50 per cent of the global demand for various vaccines, 40 per cent of the generic demand in the US, and 25 per cent of all medicine in the UK.
Express Pharma
NOVEMBER 24, 2023
Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. A vaccine manufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.
Express Pharma
JUNE 14, 2024
It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. India’s pharmaceutical industry is a global powerhouse. The second chink is its climate and environmental footprint.
pharmaphorum
JUNE 1, 2022
Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.
Quality Matters
APRIL 19, 2024
Given this dependence on foreign manufacturers, the African Union made regional production a central pillar of its New Public Health Order, and partnerships that support African-produced medicines, vaccines, and other medical products, are central to their efforts. But PEPFAR is looking to change how it does business.
Expert insights. Personalized for you.
105 
Let's personalize your content